FDA clocks record number of recalls

Share this article:

The FDA is setting a record. Regulatory Focus reports that the regulator has issued more recalls since the beginning of 2013 than it did over the previous nine years. RF says the record-breaking streak is punctuated by a spike in Class-II recalls, which means drugmakers pulled items which may cause “temporary or medically reversible adverse events.”

RF says Class-II recalls have become a mainstay of total recall numbers for a while, and that the uptick is linked to compounding pharmacies which have undergone increased scrutiny since the 2012 fungal meningitis outbreak that killed more than 60 patients.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters